Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jul 5, 2022

50715_rns_2022-07-05_acee528e-ccdb-4018-be62-13cfd0de53ce.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

5 July 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Descriptionof relevantsecurities Nature of deali ngs Purchase /Sale Totalnumberof sharesinvolved Total amounpaid / receiv ted Highest (prices pa/ receive H)idd Lowest (L)prices paid/ received
CICC FinancialTrading Limited 4 July2022 Other typesof securities(e.g. equityswaps) Closing / flattenproprietary posiunsolicited clienconfirm this wathe close of the ing / unwinding oftions arising fromt-driven dealings.s done no later thanmorning trading I Sale 68,000 $1,601,804.1 500 $23.55 67 $23.5555
session on thethe orginatingc trading day followinlient-driven dealing g

Public Disclosure Form

==> picture [71 x 43] intentionally omitted <==

Ordinaryshares Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-driven dealings. Iconfirm this was done no later thanthe close of the morning tradingsession on the trading day followingthe orginatingclient-driven dealing Purchase 68,000 $1,598,802.4000 $23.5118 $23.5118

End

Note:

CICC Financial Trading Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.

CICC Financial Trading Limited is ultimately owned by China International Capital Corporation Limited.